Close

Achillion Pharmaceuticals, Inc. (ACHN) Misses Q4 EPS by 2c; Guides FY12

March 8, 2012 7:07 AM EST
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q4 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $62 thousand versus the consensus estimate of $120 thousand.

Sees FY2012 EPS of $-0.65-$-0.70, versus the consensus of $-0.64.

For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings